← Back to Search

CBT + Exercise for Diabetes Prevention in Adolescents (CBTeX Trial)

N/A
Recruiting
Research Sponsored by Colorado State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 12-17 years
Female
Must not have
T2D/ Type 1 Diabetes (T1D) or any major medical condition (e.g. cardiovascular, renal) that would prohibit the ability to participate in exercise training
Regular medication use affecting mood, insulin, or weight, including stimulants, anti-depressants, anti-psychotics, insulin sensitizers, weight loss medications & chronic steroids
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-year
Awards & highlights
No Placebo-Only Group

Summary

This trial is researching how to prevent type 2 diabetes in teenage girls using cognitive-behavioral therapy, exercise training, or a combination of the two.

Who is the study for?
This trial is for teenage girls aged 12-17 who are at risk for type 2 diabetes due to family history, show signs of depression, and have a higher body weight for their age. They shouldn't have diabetes or major medical conditions, mental disorders like schizophrenia or eating disorders, be on mood-altering medications, or be pregnant.
What is being tested?
The study tests if cognitive-behavioral therapy (CBT), exercise training, or both can reduce stress and improve mood and physical fitness in teens at risk for diabetes. It aims to see if these interventions also lower insulin resistance which is linked to developing diabetes.
What are the potential side effects?
Potential side effects from the interventions might include discomfort during exercise and emotional distress during CBT sessions. However, these activities are generally considered safe with proper supervision.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 12 and 17 years old.
Select...
I am female.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have major health issues that prevent me from exercising.
Select...
I use medications that affect my mood, insulin levels, or weight.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Insulin Resistance
Secondary study objectives
Adiposity
BMI
Cardiorespiratory fitness
+10 more
Other study objectives
Automatic thoughts
Body image
Mindfulness
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive-Behavioral Therapy followed by Exercise TrainingExperimental Treatment1 Intervention
6-week cognitive-behavioral therapy intervention of 6 weekly 1-hour group sessions followed by a 6-week exercise training intervention of 6 weekly 1-hour group sessions
Group II: Cognitive-Behavioral Therapy OnlyActive Control1 Intervention
6-week cognitive-behavioral therapy intervention of 6 weekly 1-hour group sessions followed by an additional 6-week cognitive-behavioral therapy intervention of 6 weekly 1-hour group sessions
Group III: Exercise Training followed by Cognitive-Behavioral TherapyActive Control1 Intervention
6-week exercise training intervention of 6 weekly 1-hour group sessions followed by a 6-week cognitive-behavioral therapy intervention of 6 weekly 1-hour group sessions
Group IV: Exercise Training OnlyActive Control1 Intervention
6-week exercise training intervention of 6 weekly 1-hour group sessions followed by an additional 6-week exercise training intervention of 6 weekly 1-hour group sessions

Find a Location

Who is running the clinical trial?

Colorado State UniversityLead Sponsor
132 Previous Clinical Trials
38,127 Total Patients Enrolled
6 Trials studying Insulin Resistance
459 Patients Enrolled for Insulin Resistance
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,449 Previous Clinical Trials
4,332,167 Total Patients Enrolled
93 Trials studying Insulin Resistance
13,172 Patients Enrolled for Insulin Resistance
University of Colorado, DenverOTHER
1,806 Previous Clinical Trials
2,822,106 Total Patients Enrolled
28 Trials studying Insulin Resistance
1,652 Patients Enrolled for Insulin Resistance

Media Library

Cognitive-Behavioral Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05543083 — N/A
Insulin Resistance Research Study Groups: Cognitive-Behavioral Therapy Only, Cognitive-Behavioral Therapy followed by Exercise Training, Exercise Training followed by Cognitive-Behavioral Therapy, Exercise Training Only
Insulin Resistance Clinical Trial 2023: Cognitive-Behavioral Therapy Highlights & Side Effects. Trial Name: NCT05543083 — N/A
Cognitive-Behavioral Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05543083 — N/A
~181 spots leftby Jan 2027